Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-03T04:09:10.135Z Has data issue: false hasContentIssue false

P0131 - Plasma concentrations of aminoacids in chronic non-refractory schizophrenia and their first-degree relatives compared to refractory schizophrenia and their first degree-relatives

Published online by Cambridge University Press:  16 April 2020

J.E. Hallak
Affiliation:
Department of Neurology, Psychiatry and Psychological Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
M.T. Cunha
Affiliation:
Uberaba Medical School, University of Uberaba, Minas Gerais, Uberaba, Brazil
R.A. Gomes
Affiliation:
Uberaba Medical School, University of Uberaba, Minas Gerais, Uberaba, Brazil
A.W. Zuardi
Affiliation:
Uberaba Medical School, University of Uberaba, Minas Gerais, Uberaba, Brazil
S.M. Dursun
Affiliation:
Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Abnormalities of peripheral amino acid concentrations have been reported in schizophrenia since 1954 (Sackler, 1954), however results have been inconsistent and the neurobiological implications of these abnormalities remain unclear.

We measured serum levels of serine, glycine and glutamate in 14 chronic non-refractory patients with schizophrenia treated with traditional antipsychotics and in 12 first-degree relatives and compared the data to the serum levels from 12 refractory patients treated with clozapine and their first- degree relatives.

We found decreased serum levels of serine (p=0.048) and glutamate (p<0.001) in chronic non-refractory schizophrenia compared to refractory schizophrenia, but no differences in glycine levels.

Furthermore, the data demonstrated that first-degree relatives of non-refractory patients have increased serum levels of glycine (p=0.046)and decreased levels of glutamate (p<0.001), but no differences in serine serum levels compared to first degree-relatives of refractory patients

These data show that changes in serum amino acids may predominantly involved in central glutamatergic transmission in refractory schizophrenia. Also, it could be hypothesized that this differential pattern of serum aminoacids concentrations in first-degree relatives may be a biological marker and predictor involved in the response to antipsychotic treatments in schizophrenia patients.

Type
Poster Session I: Schizophrenia and Psychosis
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.